Results 231 to 240 of about 113,809 (305)

Early Myelination Supports the Establishment of Consistent Handedness

Glia, Volume 74, Issue 7, July 2026.
Early compact myelin is essential for the establishment but not the maintenance of consistent paw preference in mice. Congenital myelin absence reduces lateralization and creates a leftward bias, underscoring a developmental role in shaping brain asymmetries. ABSTRACT Lateralization of brain functions, such as handedness, is thought to enhance cortical
Sharlen Moore, Swati Subramanian, Martin Meschkat, Jonas W. Hemesath, Torben Ruhwedel, Wiebke Möbius, Klaus‐Armin Nave, Livia de Hoz   +7 more
wiley   +1 more source

Methodological Challenges for Ablation of BMPR1A in Hypothalamic Tanycytes-A Cautionary Tale. [PDF]

FASEB Bioadv
Tao T, Leon-Palmer N, DiPietro S, Townsend KL.   +3 more
europepmc   +1 more source

Specific Deletion of Interleukin‐1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke

Glia, Volume 74, Issue 7, July 2026.
Microglial IL‐1β deletion improves acute outcome and reduces neutrophil recruitment after experimental ischemic stroke. Microglial IL‐1β deletion increases neurogenesis in the subventricular zone after experimental ischemic stroke. ABSTRACT Interleukin‐1 (IL‐1) signaling is a major driver of post‐ischemic neuroinflammation, yet the cell‐ and isoform ...
Alba Grayston, Margarida Baptista, Kelly Wemyss, Ruby Taylor, Grace Cullen, Syeda S. Jafree, Nadim Luka, Joshua R. Cox, Joanne E. Konkel, David Brough, Stuart M. Allan, Emmanuel Pinteaux   +11 more
wiley   +1 more source

Limited Potential to Reverse Deafness Caused by Mutation of Myo7a. [PDF]

J Assoc Res Otolaryngol
Pentland DR, Blackburn J, Witting L, Kirwin DA, Steel KP.   +4 more
europepmc   +1 more source

Metastatic Cutaneous Adnexal Carcinoma of the Head and Neck With Durable Response to an Aromatase Inhibitor Combined With a Cyclin‐Dependent Kinase 4/6 Inhibitor

Head &Neck, Volume 48, Issue 7, Page E70-E75, July 2026.
ABSTRACT Background Cutaneous adnexal carcinomas are a very rare group of cancers arising from appendageal structures of the skin. More than half occur in the head and neck region. No standard treatments exist for metastatic disease. Methods A 48‐year‐old postmenopausal female presented with an enlarging scalp lesion.
Nilesh Kapoor, Manasa Narasimman, Travis Vandergriff, Amy L. Jones   +3 more
wiley   +1 more source

Desmoid Tumor of the Porta Hepatis: A Rare Location With Unusual Clinical Presentation. [PDF]

Case Reports Hepatol
Adilli A, Aliyev A, Karslıoğlu Y, Dogusoy GB, Ahmadov E, Asgarova P, Agayarlı F, Babazade I, Ibrahimli A, Ziyadova G.   +9 more
europepmc   +1 more source

A cost‐effectiveness analysis of breast cancer treatment in certified versus non‐certified hospitals in Germany

International Journal of Cancer, Volume 159, Issue 1, Page 159-172, 1 July 2026.
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin, Olaf Schoffer, Christoph Streissnig, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, Martin Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues‐van Tol, Theresa Link, Anton Scharl, Elisabeth C. Sturm‐Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt, Michael Schlander   +20 more
wiley   +1 more source

Genetic Variation in <i>CYP2B6</i>, <i>UGT1A4</i> and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. [PDF]

J Pers Med
Kruger B, Chimusa ER, Abera AB, Singh J, Shamley D, Dandara C.   +5 more
europepmc   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

International Journal of Cancer, Volume 159, Issue 1, Page 210-223, 1 July 2026.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching, Cosima Brucker, Thomas Decker, Anne Engel, Thomas Göhler, Christian Jackisch, Jan Janssen, Andreas Köhler, Kerstin Lüdtke‐Heckenkamp, Diana Lüftner, Frederik Marmé, Marion van Mackelenbergh, Beate Rautenberg, Marcus Schmidt, Rudolf Weide, Pauline Wimberger, Elena Kisseleff, Christina Pfister, Claudia Quiering, Christian Roos, Achim Wöckel   +20 more
wiley   +1 more source

Clinical Outcomes of Lobular Carcinoma <i>In Situ</i>: Risk of Invasive Cancer Development. [PDF]

J Breast Cancer
Woen D, Kim KJ, Lee SM, Lee S, Oh K, Lee CE, Nam SJ, Kim SW, Lee JE, Chae BJ, Lee SK, Ryu JM, Park WK, Lee H, Yu J.   +14 more
europepmc   +1 more source